Abbott Can't Duck $3.5M Norvir Verdict For GSK: Judge

Law360, Chicago (September 6, 2011, 7:18 PM EDT) -- A California federal judge on Tuesday shot down Abbott Laboratories' bid to duck a $3.5 million jury verdict in GlaxoSmithKline PLC's contract and antitrust suit over a licensing deal for Abbott's HIV drug Norvir, finding that the evidence at trial backed up the jury's findings.

U.S. District Judge Claudia Wilken refused to grant Abbott's renewed motion for judgment as a matter of law, upholding the verdict that the defendant had breached an implied covenant of good faith and fair dealing when it raised the price for...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.